U.S. stocks
BMRN
Report not generated
BioMarin Pharmaceutical
Enzyme therapies for rare genetic diseases
Why these companies
Selection basis
Representative companies
Rare disease drugs leader list
U.S. stocks
SRPT
Report not generated
Sarepta Therapeutics
Duchenne muscular dystrophy gene therapies
U.S. stocks
RARE
Report not generated
Ultragenyx Pharmaceutical
Rare metabolic and bone disease drugs
U.S. stocks
BBIO
Report not generated
BridgeBio Pharma
Genetic disease pipeline
U.S. stocks
PTCT
Report not generated
PTC Therapeutics
Small-molecule drugs for rare diseases
A standard report for a new stock is free for the first generation. Professional valuation is paid and uses one credit. Existing public reports are free to view.
Sources
Industry and company sources
This page is a research directory. “Representative leader” is not an official designation, a return forecast or trading advice. Valuations and reports may contain errors or outdated information; verify against company filings and authoritative sources.